USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 192 filers reported holding USANA HEALTH SCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $316,083 | +85327.8% | 5,393 | -19.0% | 0.00% | -33.3% |
| Q4 2022 | $370 | -99.9% | 6,662 | -22.6% | 0.00% | -25.0% |
| Q3 2022 | $490,000 | -26.0% | 8,602 | -12.2% | 0.00% | -20.0% |
| Q2 2022 | $662,000 | -19.1% | 9,792 | -2.6% | 0.01% | -16.7% |
| Q1 2022 | $818,000 | -16.4% | 10,052 | +1.2% | 0.01% | -14.3% |
| Q4 2021 | $978,000 | -53.6% | 9,932 | -54.2% | 0.01% | -46.2% |
| Q3 2021 | $2,109,000 | +106.2% | 21,702 | +100.5% | 0.01% | +116.7% |
| Q2 2021 | $1,023,000 | -11.7% | 10,822 | -9.7% | 0.01% | -14.3% |
| Q1 2021 | $1,159,000 | +6.0% | 11,985 | -4.9% | 0.01% | 0.0% |
| Q4 2020 | $1,093,000 | +1.5% | 12,608 | +0.5% | 0.01% | -12.5% |
| Q3 2020 | $1,077,000 | -2.3% | 12,540 | -2.9% | 0.01% | 0.0% |
| Q2 2020 | $1,102,000 | +7.7% | 12,908 | +5.7% | 0.01% | -11.1% |
| Q1 2020 | $1,023,000 | +32.7% | 12,216 | +3.0% | 0.01% | +50.0% |
| Q4 2019 | $771,000 | -14.4% | 11,864 | -2.0% | 0.01% | -14.3% |
| Q3 2019 | $901,000 | – | 12,111 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
| Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
| Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
| USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
| Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
| Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
| Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
| RQSI Ltd | 3,937 | $404,000 | 0.38% |
| CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |